JDD September Issue Highlights
Below are the issue highlights for the September issue of the JDD.
Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI.
Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various advers …
Below are the issue highlights for the September issue of the JDD.
Randomized, Double-Blinded, Split-Face Study Comparing the Efficacy and Tolerability of Two Topical Products in Melasma compares a HQ-free, retinol-free cosmetic topical brightener and HQ 4% in patients with skin types III-VI.
Complication of Soft Tissue Fillers: Prevention and Management Review highlights the various advers … 
[vc_row][vc_column][vc_column_text]EPI Health has graciously supported the COVID-19 News and Resource Center.
COVID-19 DERM TOPICS
COVID-19 Peer-reviewed Articles
Safely Reopening Derm Practices Video Series
JDD COVID-19 Webinar Series
COVID-19: Urgent Medical and Aesthetic Issues for Dermatology
Streamed live on April 1st, 2020, and now available to watch on-demand, this webinar panel provi … 
With the advent of biologics, patients with moderate-to-severe plaque psoriasis have experienced increased control of disease and improved quality of life. Tumor necrosis factor (TNF) inhibitors are some of the earliest biologics prescribed for psoriasis, psoriatic arthritis and, more recently, hidradenitis suppurativa. In this month’s installment of Therapeutic Cheat Sheets, we discuss TNF inhi … 
Here are the issue highlights and Editor Picks for the August issue of JDD:
Clearance of psoriasis leads to greater uptake of cosmetic procedures in Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement.
The Effect of Tildrakizumab on Cardiometabolic Two Phase 3 Trials (reSURFACE 1 and reSURFACE 2) examines the impact of IL-23 inhibition on c … 